A5012885934- Mosquito-borne diseases and control
- COVID-19 epidemiological studies
- COVID-19 Clinical Research Studies
- Zoonotic diseases and public health
- SARS-CoV-2 detection and testing
- SARS-CoV-2 and COVID-19 Research
- Sex work and related issues
- Business, Innovation, and Economy
- Adolescent Sexual and Reproductive Health
- Malaria Research and Control
- COVID-19 and Mental Health
- HIV, Drug Use, Sexual Risk
- Dengue and Mosquito Control Research
- Public Health and Environmental Issues
- Viral Infections and Vectors
- Scientific Research and Technology
- Otolaryngology and Infectious Diseases
- Intimate Partner and Family Violence
- Respiratory viral infections research
- COVID-19 and healthcare impacts
- Glycosylation and Glycoproteins Research
- Chemokine receptors and signaling
- Long-Term Effects of COVID-19
- Pneumonia and Respiratory Infections
- Dental Research and COVID-19
Universidad de Panamá
2020-2024
Instituto de Investigaciones Científicas y Servicios de Alta Tecnología
2018-2022
City of Knowledge
2018-2021
Acharya Nagarjuna University
2018-2020
Despite an increase in dengue outbreaks and the arrival of chikungunya Zika disease Panama, studies on demographic history invasive Aedes mosquitoes that are principle vectors these diseases still lacking this region. Here, we assess genetic diversity order to decipher their invasion histories into Isthmus Panama. DNA sequences from mitochondrial cytochrome C oxidase I gene obtained 30 localities 10 provinces confirmed presence more than one haplogroup (i.e., maternal lineage) each species....
Long term surveillance of vectors and arboviruses is an integral aspect disease prevention control systems in countries affected by increasing risk. Yet, little effort has been made to adjust space-time risk estimation integrating case counts with vector data, which may result inaccurate projection when several species are present, known about their likely role local transmission. Here, we integrate 13 years dengue associated Aedes occurrence data across 462 localities 63 districts estimate...
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of ongoing disease 2019 (COVID-19) pandemic, which has reached 28 million cases worldwide in 1 year. The serological detection antibodies against virus will play a pivotal role complementing molecular tests to improve diagnostic accuracy, contact tracing, vaccine efficacy testing, and seroprevalence surveillance. Here, we aimed first evaluate lateral flow assay's ability identify specific IgM IgG...
The Republic of Panama has the second most unequally distributed wealth in Central America, recently entered list countries affected by COVID-19 pandemic, and one largest testing rate per inhabitant region consequently highest incidence COVID-19, making it an ideal location to discuss potential scenarios for assessing epidemic preparedness, outline research opportunities Region Americas. We address two timely important questions: What are unique risks that could help other be better...
We tested 700 serum samples collected throughout Panama from 2015 to 2016 for detecting antibodies and RNA of arboviruses. In convalescent specimens, microsphere immunoassay detected an antibody prevalence 59.3% dengue virus (DENV) 30.3% Zika (ZIKV), which included that were before the Panamanian surveillance system reported first case in country. For acute sera, most common arbovirus was DENV with 18 positive (6%), followed by four (1.3%) ZIKV one (0.6%) chikungunya (CHIKV). Our results...
Abstract Long term surveillance of vectors and arboviruses is an integral aspect disease prevention control systems in countries affected by increasing risk. Yet, little effort has been made to adjust space-time risk estimation integrating case counts with vector data, which may result inaccurate projection when several species are present, known about their likely role local transmission. Here, we integrate 13 years dengue associated Aedes occurrence data across 462 localities 63 districts...
ABSTRACT Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of ongoing disease 2019 (COVID-19) pandemic, which has reached 28 million cases worldwide in eight months. The serological detection antibodies against virus will play a pivotal role complementing molecular tests to improve diagnostic accuracy, contact tracing, vaccine efficacy testing and seroprevalence surveillance. Here, we aimed first evaluate lateral flow assay’s ability identify specific...
The first patient infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Panama was reported on March 9, 2020. Here, we describe the case of recovery from disease 2019 (COVID-19) country. a 49-year-old male high school teacher, who did not show any primary symptoms COVID-19 described health authorities as signs for medical attention. Nonetheless, he became severely ill over course weeks and almost lost battle against COVID-19. closure secondary City after identification...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the causative agent of disease 2019 (COVID-19) pandemic. While research on COVID-19 has mainly focused its epidemiology, pathogenesis, and treatment, studies naso-oropharyngeal microbiota have emerged in last few years as an overlooked area research. Here, we analyzed bacterial community composition naso-oropharynx 50 suspected SARS-CoV-2 cases (43 detected, 7 not detected) from Veraguas province (Panama) distributed across...